MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'aging drugs'. Sat, 03 Sep 2011 02:53:45 +0100 http://www.medworm.com/index.php?rid=5158994&cid=t_186578_87_f&fid=39187&url=http%3A%2F%2Fgetbetterhealth.com%2Fdrug-shown-to-protect-obese-mice-from-the-diseases-of-obesity%2F2011.08.25 I usually choose not to write about the “new new scientific thing” that gets picked up by the press,  because early research is usually not reproducible and good science takes a long time to validate as true.  But since we know that mice and rats that are kept on low-calorie diets live 30% longer (and healthier) than their fat cohorts, I was interested in a new research compound, SRT-1720,  that was shown to protect obese mice from diseases of obesity.  Fat mice lived 44% longer if they were given this drug. The “designer” drug works by (more…) *This blog post was originally published at EverythingHealth* (Source: Better Health) Better Health blogs http://www.medworm.com/rss/comments.php?id=5158994 Thu, 25 Aug 2011 14:00:00 +0100 5158994 http://www.medworm.com/index.php?rid=4532181&cid=t_186578_87_f&fid=36088&url=http%3A%2F%2Fwww.ourbodiesourblog.org%2Fblog%2F2011%2F02%2Fmore-attention-to-potential-risks-from-bisphosphonates We have previously written about the apparently small risk of a rare bone fracture associated with drugs meant to prevent bone fractures in people with osteoporosis. These drugs are called bisphosphonates, known under trade names such as Fosamax and Boniva. Today, NPR’s Morning Edition has a good overview of this topic, noting the dilemma for women weighing whether to take such drugs. Bisphosphonates can help some women prevent serious hip fractures, but they may be associated with a increased risk of other atypical fractures in some women, especially those who use the drugs long-term. There’s a new study on this topic in the Journal of the American Medical Association as well. The study found that treatment with a bisphosphonate for more than five years was associated with an ... Our Bodies Our Blog blogs http://www.medworm.com/rss/comments.php?id=4532181 Mon, 28 Feb 2011 19:11:26 +0100 4532181 http://www.medworm.com/index.php?rid=4337883&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F007823.html Drugs that prevent the conversion of testosterone into dihydrotestosterone (DHT) can prevent hair loss and benign prostate hyperplasia but at the cost of adverse effects in a subset of users. (Boston) – Researchers from Boston University School of Medicine (BUSM), in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors (5a-RIs), while improving urinary symptoms in patients with benign prostatic hyperplasia (BPH) and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction (ED), ejaculatory dysfunction and potential depression. These findings, which currently appear on-line in Journal of Sexual Medicine, suggest that extreme caution should be exercise... FuturePundit blogs http://www.medworm.com/rss/comments.php?id=4337883 Wed, 12 Jan 2011 00:00:00 +0100 4337883 http://www.medworm.com/index.php?rid=4265665&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2Feq9Gk85bAWE%2F This is only a piece of the much bigger issue of how -- and what -- to prescribe to the elderly. (Source: WSJ.com: Health Blog) WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=4265665 Fri, 17 Dec 2010 18:19:32 +0100 4265665 http://www.medworm.com/index.php?rid=4258819&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F007743.html Lenalidomide, a derivative of thalidomide, was developed to treat multiple myeloma. But in low doses lenalidomide appears to reverse many immune systems which occur in some (though not all) people as they age. UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age. The team found that extremely low doses of the drug lenalidomide can stimulate the body’s immune-cell protein factories, which decrease production during aging, and rebalance the levels of several key cytokines – immune proteins that either attack viruses and bacteria or cause inflammation that leads to an overall decline in health. Blood tests could tell... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=4258819 Tue, 14 Dec 2010 00:00:00 +0100 4258819 http://www.medworm.com/index.php?rid=4219718&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FISZrV0i2Cb4%2F GSK says it won't study SRT501 further but is still waiting for data from other, completed trials. (Source: WSJ.com: Health Blog) WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=4219718 Wed, 01 Dec 2010 22:23:01 +0100 4219718 http://www.medworm.com/index.php?rid=4207279&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FEN8csuGGsXc%2F Also: Tricare fees for some military retirees in the spotlight; Amarin's anti-trigyceride drug; tax break for employer-provided health plans. (Source: WSJ.com: Health Blog) WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=4207279 Mon, 29 Nov 2010 13:28:11 +0100 4207279 http://www.medworm.com/index.php?rid=3865245&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2Fn06HuLdLJCg%2F Two GSK execs were asked to quit the nonprofit's board after the drug maker learned it was selling resveratrol supplements. (Source: WSJ.com: Health Blog) WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=3865245 Fri, 13 Aug 2010 16:44:08 +0100 3865245 http://www.medworm.com/index.php?rid=3861974&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F007402.html Would you like some fries and statins with the double cheeseburger and Coke? Fast food outlets could provide statin drugs free of charge so that customers can neutralise the heart disease dangers of fatty food, researchers at Imperial College London suggest in a new study published this week. Statins reduce the amount of unhealthy "LDL" cholesterol in the blood. A wealth of trial data has proven them to be highly effective at lowering a person's heart attack risk. In a paper published in the Sunday 15 August issue of the American Journal of Cardiology, Dr Darrel Francis and colleagues calculate that the reduction in cardiovascular risk offered by a statin is enough to offset the increase in heart attack risk... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=3861974 Wed, 11 Aug 2010 23:00:00 +0100 3861974 http://www.medworm.com/index.php?rid=3784232&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FBzdFP2c3P2w%2F What's responsible for the age-related performance declines seen in most sports? (Source: WSJ.com: Health Blog) WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=3784232 Fri, 23 Jul 2010 21:26:31 +0100 3784232 http://www.medworm.com/index.php?rid=3721750&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2F7hqo-_bcawE%2F Also: legal battles over health-care overhaul begin; AstraZeneca gets fined by an E.U. court; excess swine flu vaccine stocks headed for the trash. (Source: WSJ.com: Health Blog) WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=3721750 Fri, 02 Jul 2010 12:36:40 +0100 3721750 http://www.medworm.com/index.php?rid=3577375&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FW5__AOiVKmU%2F Until this month, there wasn't much solid evidence that HGH improves aspects of athletic performance. (Source: WSJ.com: Health Blog) WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=3577375 Wed, 19 May 2010 14:14:33 +0100 3577375 http://www.medworm.com/index.php?rid=3533807&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FAzPCN0B9hSw%2F A small GlaxoSmithKline trial of a drug called SRT501, a rejiggered version of resveratrol, has been halted on safety concerns. (Source: WSJ.com: Health Blog) WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=3533807 Wed, 05 May 2010 13:24:10 +0100 3533807 http://www.medworm.com/index.php?rid=3448813&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F007083.html Do drugs that block the conversion of testosterone into dihydrotestosterone reduce the risk of prostate cancer? Results from a large, randomized clinical trial indicate that men at an increased risk for prostate cancer reduced their risk with regular use of the drug dutasteride (Avodart). The results came from the REDUCE trial, which is the second largest clinical trial to demonstrate a decreased risk of prostate cancer in men taking an agent from the class of drugs known as 5-α reductase inhibitors (5-αRIs). Previously, the Prostate Cancer Prevention Trial (PCPT) showed that the drug finasteride had a risk reduction similar to what has now been seen in REDUCE. These drugs also slow or stop male pattern baldness as well as controlling... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=3448813 Tue, 06 Apr 2010 23:00:00 +0100 3448813 http://www.medworm.com/index.php?rid=3354294&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FVcZ3iFmdiTQ%2F There have long been safety questions — and lawsuits — over whether bone-building drugs like Merck’s Fosamax can actually increase the chance of femur fractures. Today, the FDA said it was going to take another look at the safety issues. In a posting on its Web site, the FDA said a 2008 examination of data from makers of osteoporosis drugs containing bisphosphonates didn’t show that women taking the medications had an increased risk of fracturing their femurs — the bone just below the hip joint. But studies released today at the annual meeting of the American Academy of Orthopaedic Surgeons raised new questions about the risks for long-term use of bisphosphonates by post-menopausal women. USA Today has more. In its latest review, the FDA said it would work wi... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=3354294 Wed, 10 Mar 2010 22:55:12 +0100 3354294 http://www.medworm.com/index.php?rid=3306814&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FEkajUOAz_rQ%2F Last we heard of Fablyn, an experimental bone drug for the treatment of postmenopausal women, U.S. regulators were holding off on approval after FDA staff and outside reviewers raised concerns and Pfizer, the pill’s maker, was shopping it around to other companies. Today’s New England Journal of Medicine reports that the drug met the goals of a key study. Fablyn prevented certain fractures in postmenopausal women and reduced the risk of breast cancer, said the study, sponsored by Pfizer. However, the drug didn’t show a statistically significant benefit preventing debilitating hip fractures. Also, it increased the risk of blood clots by two times. The Phase 3 study looked at 8,556 women between the ages 59 and 80 over five years. Its mixed results aren’t likely to c... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=3306814 Thu, 25 Feb 2010 16:28:45 +0100 3306814 http://www.medworm.com/index.php?rid=3212290&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F006901.html Low growth hormone among dwarves in a state in Brazil does not shorten their life expectancies. People profoundly deficient in human growth hormone (HGH) due to a genetic mutation appear to live just as long as people who make normal amounts of the hormone, a new study shows. The findings suggest that HGH may not be the "fountain of youth" that some researchers have suggested. "Without HGH, these people still live long, healthy lives, and our results don't seem to support the notion that lack of HGH slows or accelerates the aging process," says Roberto Salvatori, M.D., associate professor in the Department of Endocrinology at the Johns Hopkins University School of Medicine. The researchers, working with an unusual population of... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=3212290 Tue, 26 Jan 2010 00:00:00 +0100 3212290 http://www.medworm.com/index.php?rid=2993739&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F006714.html Gina Kolata, writing in the New York Times talks to a lot of top medical researchers and reports on cancer-preventing drugs that go unused and the many disappointing diet and vitamin interventions for cancer prevention. Many Americans do not think twice about taking medicines to prevent heart disease and stroke. But cancer is different. Much of what Americans do in the name of warding off cancer has not been shown to matter, and some things are actually harmful. Yet the few medicines proved to deter cancer are widely ignored. The article does an excellent job of reviewing assorted great hopes for reduced cancer risk via diet and vitamins and how many of these approaches failed in large scale intervention trials.... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=2993739 Sun, 15 Nov 2009 00:00:00 +0100 2993739 http://www.medworm.com/index.php?rid=2943742&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F006665.html Might a widely available cholesterol-lowering drug slow or stop the progression of Parkinson's? (CHICAGO) –Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease. If this happens in humans surely some doctors would have noticed by now? Since Simvastatin is sold by Merck as Zocor and since at least some older patients with Parkinson's also have high cholesterol I wonder how difficult it would be to measure Parkinson's progression in patients already taking Zoc... FuturePundit blogs http://www.medworm.com/rss/comments.php?id=2943742 Thu, 29 Oct 2009 00:00:00 +0100 2943742 http://www.medworm.com/index.php?rid=2883003&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F006615.html Heather Mac Donald thinks the rhetoric promoting the potential for disease prevention by doctors is overblown. We need to induce doctors to practice preventive, not just reactive, care! is a... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=2883003 Sat, 10 Oct 2009 23:00:00 +0100 2883003 http://www.medworm.com/index.php?rid=2719679&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FZAD5138VE2U%2F Most people who are 55 and older take one or more prescription drugs that may affect their ability to drive safely — but most of them are unaware of the risks, according to a new survey. In all, 69% of those surveyed took a medicine that could impair driving, because of possible side effects such as dizziness, drowsiness or blurred vision. But only 28% of respondents were aware of those issues. Only 18% had been warned about the possible driving risks by a doctor, nurse of pharmacist. The older patients were, the more likely they were to be taking multiple drugs that might cause problems with driving — and the less likely they were to be aware of the issue. The telephone survey, funded by a foundation affiliated with AAA and conducted by academic researchers, included responses... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=2719679 Thu, 20 Aug 2009 14:28:59 +0100 2719679 http://www.medworm.com/index.php?rid=2634378&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F006388.html Not all blood pressure drugs are equal in protection provided against brain function decline with age. The angiotensin-converting enzyme (ACE) inhibitors are better for the brain than other blood pressure... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=2634378 Tue, 21 Jul 2009 23:00:00 +0100 2634378 http://www.medworm.com/index.php?rid=2477671&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F006293.html Should older men take testosterone as a replacement therapy for declining natural testosterone levels? In middle-aged and older men with low testosterone levels, long-term testosterone replacement therapy greatly improves their... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=2477671 Tue, 16 Jun 2009 04:00:00 +0100 2477671 http://www.medworm.com/index.php?rid=2273750&cid=t_186578_122_f&fid=35056&url=http%3A%2F%2Fwww.renegadeneurologist.com%2Fthe-truth-about-hormone-therapy%2F From: Wall Street Journal Online Mainstream medicine has been given a wake-up call on a matter critical to the health of 65 million women in the U.S. At issue are the options for treatment of menopause symptoms that cause significant health problems for women in mid-life as their bodies produce fewer hormones. It doesn’t seem like a complicated problem, given advances in medical science. Yet hormone-replacement therapy has become a textbook example of how special interests, a confused medical establishment, and opportunists can combine to complicate the issue and deny patients access to safe and effective treatments. Until seven years ago, women going to conventional doctors were prescribed the FDA-approved synthetic hormone Premarin, derived from the urine of pregnant horses; Prover... Renegade Neurologist - A Blog by David Perlmutter, MD, FACN blogs http://www.medworm.com/rss/comments.php?id=2273750 Tue, 17 Mar 2009 11:14:34 +0100 2273750 http://www.medworm.com/index.php?rid=2227214&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F006005.html Statins might cause problems for some people by reducing brain synthesis of cholesterol. AMES, Iowa -- Research by an Iowa State University scientist suggests that cholesterol-reducing drugs known as statins... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=2227214 Mon, 02 Mar 2009 05:00:00 +0100 2227214 http://www.medworm.com/index.php?rid=2187744&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F005966.html A drug under development boosts lean muscle mass in older adults. This is pretty gutsy for a drug company to do active development on what is basically a rejuvenation drug... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=2187744 Sun, 15 Feb 2009 05:00:00 +0100 2187744 http://www.medworm.com/index.php?rid=2182597&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F005961.html Statins cut death risk. Varda Shalev, M.D., and colleagues at Maccabi Healthcare Services and Sackler Faculty of Medicine, Tel Aviv, Israel, analyzed data from 229,918 adults (average age 57.6) enrolled... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=2182597 Wed, 11 Feb 2009 05:00:00 +0100 2182597 http://www.medworm.com/index.php?rid=2068009&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2FT6ulB27ng5I%2F There’s this stuff online, Vivix, billed as “the world’s best anti-aging supplement.” It’s grape-flavored. Of course, tons of supplements with uncertain effects are promoted like this online. But this one’s caught our eye because David Sinclair, a Harvard researcher who’s done some high-profile aging research, was paid to be on the scientific advisory board of Shaklee, the supplement company that sells Vivix. The WSJ has the story. At a conference last summer, the WSJ says, Sinclair (pictured) told Shaklee salespeople that “over a year ago, we set out together to do this, to make a product that you could actually activate these genetic pathways that can slow down aging.” As the video at left shows, he also said: “Together, as p... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=2068009 Sun, 28 Dec 2008 12:44:54 +0100 2068009 http://www.medworm.com/index.php?rid=1933225&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F005684.html SRT1720 for your pet mouse that refuses to stop eating junk food. A potential longevity-enhancing drug has passed its final animal testing challenge, pushing closer to reality the dream of... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=1933225 Tue, 04 Nov 2008 05:00:00 +0100 1933225 http://www.medworm.com/index.php?rid=1581929&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F005336.html Resveratrol, a compound found in red wine, reduces decay in middle aged (1 year old) mice and, depending on the diet, extends life expectancy. CAMBRIDGE, Mass., July 3, 2008 --... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=1581929 Sat, 05 Jul 2008 04:00:00 +0100 1581929 http://www.medworm.com/index.php?rid=1501296&cid=t_186578_87_f&fid=34902&url=http%3A%2F%2Fwww.futurepundit.com%2Farchives%2F005258.html A report in Plos One finds that in mice resveratrol causes a change in gene expression patterns very similar to that seen with calorie restriction diets. Resveratrol might extend life... (Source: FuturePundit) FuturePundit blogs http://www.medworm.com/rss/comments.php?id=1501296 Sat, 07 Jun 2008 04:00:00 +0100 1501296 http://www.medworm.com/index.php?rid=1394072&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2F276430652%2F This just in: GlaxoSmithKline says it will acquire Sirtris Pharmaceuticals, a Massachusetts company that’s developing a drug based on resveratrol, a chemical found in red wine that is thought to fight some effects of aging. Glaxo said in a news release that the $720 million deal will help it get involved with sirtuins, a recently-discovered class of enzymes believed to have a role in the aging process. Sirtris said early this year that its red-wine drug, which targets the sirtuin 1 enzyme, was well-tolerated and safe for patients in an early study in diabetics. It’s still early to tell whether the drug, code named SRT501, will work out. In the meantime, Sirtris has also been working on some new compounds that it says mimic the effects of resveratrol but with much more potency... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=1394072 Wed, 23 Apr 2008 21:36:26 +0100 1394072 http://www.medworm.com/index.php?rid=1382709&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2F272914375%2F Lots of systems deteriorate in the aging body; sometimes in trying to fix one thing, you end up making another thing worse. For example, popular drugs for urinary incontinence may speed age-related memory loss, researchers said yesterday. iStockphoto Prompted by anecdotal reports of patients having memory problems after going on a class of drugs that includes Pfizer’s Detrol LA, researchers looked at data from a long-term neurologic study. They were able to compare 679 people who took the drugs with 191 who did not. Over the course of several years, those who took the drugs lost their memory faster than those who did not. The drugs act on a class of chemicals used to transmit messages in the nervous system. The findings come from an analysis of the medication use and cognitive tes... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=1382709 Fri, 18 Apr 2008 21:04:50 +0100 1382709 http://www.medworm.com/index.php?rid=1258924&cid=t_186578_87_f&fid=36224&url=http%3A%2F%2Ffeeds.wsjonline.com%2F%7Er%2Fwsj%2Fhealth%2Ffeed%2F%7E3%2F241629526%2F An extra shot of testosterone may make some aging men stronger and happier, but clear clinical data on the risks and benefits for many potential uses are still lacking, Melinda Beck reports in this week’s Health Journal column. “If we had a drug that could restore sexual function in men, make them stronger, build their bones, reduce fat and get rid of the blues, you’d say, ‘Oh my God, why doesn’t everybody know about it?’” Abraham Morgentaler, a urologist at Harvard Medical School and director of the Men’s Health Boston clinic, told Beck. “There is a drug like that — but the public associates testosterone with cheating and illicit behavior and the fact that 40 years ago, it was thought to give people prostate cancer.” Beck n... WSJ.com: Health Blog blogs http://www.medworm.com/rss/comments.php?id=1258924 Tue, 26 Feb 2008 22:01:37 +0100 1258924